Skip to content

Prognostic Value of Series Follow-up Coronary CTA in Non-obstructive Coronary Artery Disease: A Chinese Multicenter Study

Prognostic Value of Series Follow-up Coronary CTA in Non-obstructive Coronary Artery Disease: A Chinese Multicenter Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058225
Enrollment
Unknown
Registered
2022-04-03
Start date
2022-05-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-obstructive Coronary Artery Disease

Interventions

Group 1 :Series follow-up CCTA
Group 2:No serial CCTA follow-up

Sponsors

Jinling Hospital (General Hospital of Eastern Theater Command)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with non-obstructive coronary artery disease found on CCTA (20-50% heaviest coronary artery stenosis (left main coronary artery) or 20-70% (other coronary artery)); 2. Patients who agree to participate in a series of CCTA follow-up and cooperate to complete the follow-up observation.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years or older than 80 years; 2. Pregnant or lactating women; 3. Allergy to iodine contrast agent; 4. Patients with acute coronary syndrome; 5. Patients after coronary revascularization; 6. Abnormal origin and termination of coronary arteries; 7. Complex congenital heart disease; 8. After previous heart transplantation or valve replacement; 9. Patients suffering from any active, serious life-threatening disease; 10. CCTA image quality is poor; 11. Data is lost.

Design outcomes

Primary

MeasureTime frame
major adverse cardiovascular events;

Secondary

MeasureTime frame
cardiovascular death;atrial fibrillation;Non-fatal myocardial infarction;Non-fatal stroke;unplanned revascularization;unplanned revascularization;medication adjustment;medication adjustment;cumulative radiation exposure;total cardiac costs;

Countries

China

Contacts

Public ContactLongjiang Zhang

Jinling Hospital (General Hospital of Eastern Theater Command)

kevinzhlj@163.com+86 13405833176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026